Mersana Therapeutics, Inc. (MRSN)
28.21
+0.07
(+0.25%)
USD |
NASDAQ |
Dec 10, 14:38
Mersana Therapeutics Market Cap: 140.64M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Day One Biopharmaceuticals, Inc. | 874.80M |
| Cidara Therapeutics, Inc. | 6.914B |
| Cue Biopharma, Inc. | 38.58M |
| Scholar Rock Holding Corp. | 4.563B |
| ETHZilla Corp. | 6.184M |
Market Cap Related Metrics
| PS Ratio | 54.84 |
| PEG Ratio | -0.0021 |
| Price | 28.21 |
| Earnings Yield | -33.44% |
| PEGY Ratio | -0.0021 |